Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Evans, CP"'
Autor:
Evans, CP
In turn of the century Tasmania (as in most of the western world), middleclass representations of childhood meant that, increasingly, children were seen, not as a source of labour for their parents, but as dependents; innocent, vulnerable creatures w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b220a285b95c8f631eeea00d0c2a54
Autor:
Lombard, AP, Liu, L, Cucchiara, V, Liu, C, Armstrong, CM, Zhao, R, Yang, JC, Lou, W, Evans, CP, Gao, AC
Publikováno v:
Molecular cancer therapeutics, vol 17, iss 10
Lombard, AP; Liu, L; Cucchiara, V; Liu, C; Armstrong, CM; Zhao, R; et al.(2018). Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics, 17(10), 2197-2205. doi: 10.1158/1535-7163.MCT-17-1269. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/8707b0x5
Lombard, AP; Liu, L; Cucchiara, V; Liu, C; Armstrong, CM; Zhao, R; et al.(2018). Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics, 17(10), 2197-2205. doi: 10.1158/1535-7163.MCT-17-1269. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/8707b0x5
© 2018 American Association for Cancer Research. Current treatments for castration resistant prostate cancer (CRPC) largely fall into two classes: androgen receptor (AR)targeted therapies such as the next-generation antiandrogen therapies (NGAT), en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08c7cac403cc3982d00962df7835af4e
https://escholarship.org/uc/item/8707b0x5
https://escholarship.org/uc/item/8707b0x5
Autor:
Gillessen, S, Attard, G, Beer, TM, Beltran, H, Bossi, A, Bristow, R, Carver, B, Castellano, D, Chung, BH, Clarke, N, Daugaard, G, Davis, ID, de Bono, J, Borges dos Reis, R, Drake, CG, Eeles, R, Efstathiou, E, Evans, CP, Fanti, S, Feng, F, Fizazi, K, Frydenberg, M, Gleave, M, Halabi, S, Heidenreich, A, Higano, CS, James, N, Kantoff, P, Kellokumpu-Lehtinen, PL, Khauli, RB, Kramer, G, Logothetis, C, Maluf, F, Morgans, AK, Morris, MJ, Mottet, N, Murthy, V, Oh, W, Ost, P, Padhani, AR, Parker, C, Pritchard, CC, Roach, M, Rubin, MA, Ryan, C, Saad, F, Sartor, O, Scher, H, Sella, A, Shore, N, Smith, M, Soule, H, Sternberg, CN, Suzuki, H, Sweeney, C, Sydes, MR, Tannock, I, Tombal, B, Valdagni, R, Wiegel, T, Omlin, A
Publikováno v:
Gillessen, S; Attard, G; Beer, TM; Beltran, H; Bossi, A; Bristow, R; et al.(2018). Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure presented]. European Urology, 73(2), 178-211. doi: 10.1016/j.eururo.2017.06.002. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/35r8p27w
© 2017 European Association of Urology Background In advanced prostate cancer (APC), successful drug development as well as advances in imaging and molecular characterisation have resulted in multiple areas where there is lack of evidence or low lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::f32df29474e6cca620916a1041804d21
http://www.escholarship.org/uc/item/35r8p27w
http://www.escholarship.org/uc/item/35r8p27w
Autor:
Beer, Tm, Armstrong, Aj, Rathkopf, De, Loriot, Y, Sternberg, Cn, Higano, Cs, Iversen, P, Bhattacharya, S, Carles, J, Chowdhury, S, Davis, Id, de Bono JS, Evans, Cp, Fizazi, K, Joshua, Am, Kim, Cs, Kimura, G, Mainwaring, P, Mansbach, H, Miller, K, Noonberg, Sb, Perabo, F, Phung, D, Saad, F, Scher, Hi, Taplin, Me, Venner, Pm, Tombal, B, Prevail, Investigators, Scagliotti, Giorgio Vittorio
Publikováno v:
The New England journal of medicine, vol 371, iss 5
New England Journal of Medicine, 371(5), 424-433. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 371, 424-33
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (5), pp.424-433. ⟨10.1056/NEJMoa1405095⟩
The New England Journal of Medicine, 371, 5, pp. 424-33
New England Journal of Medicine, 371(5), 424-433. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 371, 424-33
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (5), pp.424-433. ⟨10.1056/NEJMoa1405095⟩
The New England Journal of Medicine, 371, 5, pp. 424-33
Contains fulltext : 137932.pdf (Publisher’s version ) (Open Access) BACKGROUND: Enzalutamide is an oral androgen-receptor inhibitor that prolongs survival in men with metastatic castration-resistant prostate cancer in whom the disease has progresse
Autor:
Nelson, EC, Evans, CP
Publikováno v:
INTERNATIONAL BRAZ J UROL, vol 34, iss 1
Nelson, EC; & Evans, CP. (2008). Evaluation of Core and Surface Body Temperatures, Prevalence, Onset, Duration and Severity of Hot Flashes in Men after Bilateral Orchidectomy for Prostate Cancer EDITORIAL COMMENT. INTERNATIONAL BRAZ J UROL, 34(1), 22-22. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0t24z46f
Nelson, EC; & Evans, CP. (2008). Evaluation of Core and Surface Body Temperatures, Prevalence, Onset, Duration and Severity of Hot Flashes in Men after Bilateral Orchidectomy for Prostate Cancer EDITORIAL COMMENT. INTERNATIONAL BRAZ J UROL, 34(1), 22-22. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0t24z46f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a75d8e738e12767cf1b21329ee6a09b0
https://escholarship.org/uc/item/0t24z46f
https://escholarship.org/uc/item/0t24z46f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.